CAS: 1629013-22-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK-3368715 REF: 3D-EQC01322CAS: 1629013-22-4 | Min. 95% | To inquire | Tue 17 Dec 24 |
 | GSK3368715 REF: TM-T11500CAS: 1629013-22-4 | 98% | 1,656.00 €~4,583.00 € | Tue 04 Feb 25 |
 | GSK3368715 REF: IN-DA01T234CAS: 1629013-22-4 | 97% | - - - | Discontinued product |
GSK-3368715
CAS:1629013-22-4
GSK-3368715 is an experimental drug that is being used to treat cancer. It has shown …
Formula:
C20H38N4O2
Purity:
Min. 95%
Molecular weight:
366.55 g/mol
Ref: 3D-EQC01322
| 10mg | 308.00 € | ||
| 100mg | 1,155.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
GSK3368715
CAS:1629013-22-4
GSK3368715 is an orally active, reversible, and S-adenosyl-L-methionine (SAM) uncompetitive type I protein arginine methyltransferases …
Formula:
C20H38N4O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
366.54
Ref: TM-T11500
| 25mg | 2,523.00 € | ||
| 50mg | 3,348.00 € | ||
| 100mg | 4,583.00 € |
Estimated delivery in United States, on Tuesday 4 Feb 2025
Ref: IN-DA01T234
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information |
